Xtant Medical Holdings, Inc. (XTNT)

NYSEAMERICAN: XTNT · Real-Time Price · USD

0.3315

+0.0265 (8.69%)

At close: Aug 17, 2026, 4:00 PM EDT

0.3100

-0.0215 (-6.49%)

Pre-market: Aug 18, 2026, 4:26 AM EDT

Xtant Medical Holdings Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	109.53	133.93	117.27	91.3	57.97	55.26
Revenue Growth	-14.27%	14.21%	28.44%	57.50%	4.90%	3.61%
Gross Profit	65.05	84.27	68.22	55.47	32.14	32.49
Operating Income	-5.5	7.28	-12.07	-10.16	-6.76	-3.25
Net Income	-11.14	4.97	-16.45	0.66	-8.49	-4.85
Earnings Per Share	-0.08	0.03	-0.12	0.01	-0.09	-0.06
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	103.37	122.45	105.52	85.86	57.16	54.57
Rest of World	6.16	11.48	11.75	5.44	0.81	0.69
Total	109.53	133.93	117.27	91.3	57.97	55.26

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	9.87	17.05	6.2	5.72	20.3	18.24
Total Debt	26.01	28.72	35.14	23.56	17.07	16.85
Net Cash (Debt)	-16.14	-11.66	-28.94	-17.84	3.23	1.4
Net Cash Growth	-	-	-	-	130.76%	-
Net Cash Per Share	-0.12	-0.08	-0.22	-0.14	0.03	0.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	0.57	12.55	-11.9	-9.52	-5.34	0.44
Capital Expenditures	-1.27	-2.38	-4.11	-1.46	-1.76	-2.12
Free Cash Flow	-0.7	10.16	-16.01	-10.97	-7.11	-1.68
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	59.39%	62.92%	58.17%	60.75%	55.44%	58.79%
Operating Margin	-5.02%	5.44%	-10.30%	-11.13%	-11.65%	-5.89%
Pretax Margin	-8.44%	5.23%	-13.87%	-1.14%	-14.52%	-8.77%
Profit Margin	-10.17%	3.71%	-14.03%	0.72%	-14.64%	-8.77%
FCF Margin	-0.64%	7.59%	-13.65%	-12.02%	-12.26%	-3.03%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	22.07	-	222.77	-	-
Forward PE	-	171.25	171.25	171.25	171.25	171.25
P/FCF Ratio	-	10.80	-	-	-	-
PS Ratio	0.42	0.82	0.53	1.61	1.24	0.88